On Tuesday, FibroGen Inc (NASDAQ: FGEN) opened lower -7.45% from the last session, before settling in for the closing price of $0.57. Price fluctuations for FGEN have ranged from $0.18 to $2.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -8.26%. Company’s average yearly earnings per share was noted 72.60% at the time writing. With a float of $93.69 million, this company’s outstanding shares have now reached $100.77 million.
Let’s determine the extent of company efficiency that accounts for 486 employees. In terms of profitability, gross margin is 76.87%, operating margin of -62.75%, and the pretax margin is -69.56%.
FibroGen Inc (FGEN) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of FibroGen Inc is 7.02%, while institutional ownership is 45.46%. The most recent insider transaction that took place on Jun 12 ’24, was worth 25,884. In this transaction Chief Medical Officer of this company bought 22,123 shares at a rate of $1.17, taking the stock ownership to the 82,123 shares. Before that another transaction happened on Mar 07 ’24, when Company’s CEO bought 50,000 for $1.91, making the entire transaction worth $95,470. This insider now owns 470,178 shares in total.
FibroGen Inc (FGEN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.60% per share during the next fiscal year.
FibroGen Inc (NASDAQ: FGEN) Trading Performance Indicators
Check out the current performance indicators for FibroGen Inc (FGEN). In the past quarter, the stock posted a quick ratio of 1.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.23, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of FibroGen Inc (FGEN)
Looking closely at FibroGen Inc (NASDAQ: FGEN), its last 5-days average volume was 0.98 million, which is a drop from its year-to-date volume of 1.63 million. As of the previous 9 days, the stock’s Stochastic %D was 19.26%. Additionally, its Average True Range was 0.07.
During the past 100 days, FibroGen Inc’s (FGEN) raw stochastic average was set at 60.89%, which indicates a significant increase from 17.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 116.83% in the past 14 days, which was higher than the 103.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4377, while its 200-day Moving Average is $0.7067. However, in the short run, FibroGen Inc’s stock first resistance to watch stands at $0.5568. Second resistance stands at $0.5836. The third major resistance level sits at $0.5971. If the price goes on to break the first support level at $0.5165, it is likely to go to the next support level at $0.5030. Should the price break the second support level, the third support level stands at $0.4762.
FibroGen Inc (NASDAQ: FGEN) Key Stats
There are currently 100,770K shares outstanding in the company with a market cap of 53.42 million. Presently, the company’s annual sales total 147,750 K according to its annual income of -284,230 K. Last quarter, the company’s sales amounted to 46,330 K and its income totaled -17,080 K.
